Utah Medical Products Statistics
Total Valuation
UTMD has a market cap or net worth of $206.96 million. The enterprise value is $118.80 million.
Important Dates
The next estimated earnings date is Tuesday, January 28, 2025, before market open.
| Earnings Date | Jan 28, 2025 |
| Ex-Dividend Date | Dec 16, 2024 |
Share Statistics
UTMD has 3.39 million shares outstanding. The number of shares has decreased by -1.90% in one year.
| Current Share Class | 3.39M |
| Shares Outstanding | 3.39M |
| Shares Change (YoY) | -1.90% |
| Shares Change (QoQ) | -1.52% |
| Owned by Insiders (%) | 6.89% |
| Owned by Institutions (%) | 66.51% |
| Float | 2.93M |
Valuation Ratios
The trailing PE ratio is 14.25.
| PE Ratio | 14.25 |
| Forward PE | n/a |
| PS Ratio | 4.93 |
| Forward PS | n/a |
| PB Ratio | 1.69 |
| P/TBV Ratio | 1.94 |
| P/FCF Ratio | 12.24 |
| P/OCF Ratio | 12.01 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 5.89, with an EV/FCF ratio of 7.02.
| EV / Earnings | 7.79 |
| EV / Sales | 2.70 |
| EV / EBITDA | 5.89 |
| EV / EBIT | 6.96 |
| EV / FCF | 7.02 |
Financial Position
The company has a current ratio of 29.59, with a Debt / Equity ratio of 0.00.
| Current Ratio | 29.59 |
| Quick Ratio | 26.83 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.31% and return on invested capital (ROIC) is 8.59%.
| Return on Equity (ROE) | 12.31% |
| Return on Assets (ROA) | 8.18% |
| Return on Capital (ROIC) | 8.59% |
| Revenue Per Employee | $231,989 |
| Profits Per Employee | $80,305 |
| Employee Count | 190 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 1.93 |
Taxes
In the past 12 months, UTMD has paid $2.95 million in taxes.
| Income Tax | 2.95M |
| Effective Tax Rate | 16.19% |
Stock Price Statistics
The stock price has decreased by -27.01% in the last 52 weeks. The beta is 0.08, so UTMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -27.01% |
| 50-Day Moving Average | 64.91 |
| 200-Day Moving Average | 67.23 |
| Relative Strength Index (RSI) | 25.31 |
| Average Volume (20 Days) | 20,735 |
Short Selling Information
The latest short interest is 64,535, so 1.90% of the outstanding shares have been sold short.
| Short Interest | 64,535 |
| Short Previous Month | 55,264 |
| Short % of Shares Out | 1.90% |
| Short % of Float | 2.20% |
| Short Ratio (days to cover) | 2.77 |
Income Statement
In the last 12 months, UTMD had revenue of $44.08 million and earned $15.26 million in profits. Earnings per share was $4.28.
| Revenue | 44.08M |
| Gross Profit | 25.92M |
| Operating Income | 17.07M |
| Pretax Income | 18.81M |
| Net Income | 15.26M |
| EBITDA | 20.17M |
| EBIT | 17.07M |
| Earnings Per Share (EPS) | $4.28 |
Full Income StatementBalance Sheet
The company has $88.45 million in cash and $299,000 in debt, giving a net cash position of $88.15 million or $25.99 per share.
| Cash & Cash Equivalents | 88.45M |
| Total Debt | 299,000 |
| Net Cash | 88.15M |
| Net Cash Per Share | $25.99 |
| Equity (Book Value) | 124.20M |
| Book Value Per Share | 36.10 |
| Working Capital | 98.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $17.23 million and capital expenditures -$311,000, giving a free cash flow of $16.92 million.
| Operating Cash Flow | 17.23M |
| Capital Expenditures | -311,000 |
| Free Cash Flow | 16.92M |
| FCF Per Share | $4.99 |
Full Cash Flow StatementMargins
Gross margin is 58.80%, with operating and profit margins of 38.73% and 34.62%.
| Gross Margin | 58.80% |
| Operating Margin | 38.73% |
| Pretax Margin | 41.30% |
| Profit Margin | 34.62% |
| EBITDA Margin | 45.77% |
| EBIT Margin | 38.73% |
| FCF Margin | 38.38% |